Expression of JC virus T-antigen in a patient with MS and glioblastoma multiforme

L Del Valle1, S Delbue, J Gordon

  • 1Center for Neurovirology and Cancer Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.

Neurology
|March 27, 2002
PubMed
Abstract

Insights

The JC virus genome and T-antigen were found in the brain of a patient with both multiple sclerosis (MS) and glioblastoma multiforme. This suggests a potential association between JC virus and these neurological conditions.

Area of Science:

  • Neurovirology
  • Oncology
  • Neuropathology

Background:

  • Investigated a rare case of concurrent multiple sclerosis (MS) and glioblastoma multiforme (GBM) in an immunocompetent patient.
  • Examined the presence and expression of the human polyomavirus JC virus (JCV) in affected brain tissues.

Observation:

  • JC virus DNA was detected in both demyelinated plaques and the glioblastoma tumor.
  • Specific JCV regulatory sequences, matching Mad-4 and W1 isolates, were identified in the tumor and MS lesions.

Findings:

  • The viral oncoprotein T-antigen was expressed in neoplastic cells and in neurons and astrocytes near MS plaques.
  • While T-antigen was present, viral capsid proteins were absent, indicating no productive JCV replication.
  • The tumor suppressor protein p53 was detected in neoplastic cells, but its expression was not linked to T-antigen presence.

Implications:

  • Provides molecular and clinical evidence linking JC virus to the brain in patients with concurrent glioblastoma and MS.
  • Suggests a potential role for JC virus in the pathogenesis of either or both conditions.
  • Highlights the need for further research into JCV's involvement in neurological diseases.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Glial Cells01:04

Glial Cells

Overview
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...